INS and diabetes mellitus: The percentages of patients with diabetes and insulin treatment were lower in those who received PAI with dexamethasone than in those who received PAI alone (16.6% vs 47.3%, P < 0.001 and 0.5% vs 10.9%, P < 0.001, respectively).